Table 1 Overview of the evaluated parameters

–

189

86.7%

164

13.2%

25

–

Age (years)

67 (63; 72)

min. 43, max. 91

–

67 (62; 72)

min. 49, max. 91

–

70 (63; 79)

min. 43, max. 88

–

0.033^#

Female

71.4%

135

70.7%

116

76.0%

19

0.812^§

Axial length (mm)

23.23 (22.52; 23.64)

min. 23.44, max. 31.71)

–

23.44 (22.95; 24.37)

min. 20.97, max. 31.71)

–

23.23 (22.52; 23.64)

min. 20.9, max. 28.12)

–

0.061^#

Pseudophakia

27.5%

52

25.6%

42

40.0%

10

0.153^§

Duration of symptoms (days)

49 (21; 150)

min. 1, max. 720

–

42 (21; 120)

min. 1, max. 720

–

105 (21; 270)

min. 14, max. 720

–

0.097^#

VA preop (logMAR)

0.7 (0.5; 1.0)

min. 0.1, max. 1.5

–

0.7 (0.5; 1.0)

min. 0.1, max. 1.5

–

1.0 (0.8; 1.0)

min. 0.4, max. 1.5

–

0.0002^#

MLD (μm)

299 (209; 414.5)

min. 19, max. 1.067

–

281.5 (198; 371)

min. 19, max. 914

–

559 (444; 633)

min. 342, max. 1.067

–

< 0.0001^#

BD (μm)

793 (537.5; 1046)

min. 163, max. 2147

–

752 (522; 958)

min. 163, max. 1674

–

1219 (1028; 1668)

min. 622, max. 2.147

–

< 0.0001^#

H (μm)

432 (374; 492)

min. 203, max. 819

–

422.5 (365; 477)

min. 203, max. 819

–

506 (462; 594)

min. 336, max. 763

–

< 0.0001^#

MHI

0.56 (0.44; 0.75)

min. 0.24, max. 1.72

–

0.61 (0.48; 0.76)

min. 0.24, max. 1.72

–

0.39 (0.35; 0.49)

min. 0.25, max. 0.67

–

< 0.0001^#

DHI

0.41 (0.31; 0.50)

min. 0.03, max. 0.92

–

0.39 (0.30; 0.50)

min. 0.03, max. 0.92

–

0.43 (0.37; 0.55)

min. 0.21, max. 0.72

–

0.185^#

THI

1.43 (1.10; 1.97)

min. 0.47, max. 19.27

–

1.55 (1.20; 2.05)

min. 0.47, max. 19.27

–

0.90 (0.74; 1.17)

min. 0.58, max. 1.65

–

< 0.0001^#

Ar (mm2)

0.09 (0.06; 0.18)

min. 0.01, max. 1.26

–

0.08 (0.05; 0.15)

min. 0.01, max. 1.26

–

0.27 (0.19; 0.36)

min. 0.09, max. 0.96

–

< 0.0001^#

Cy (pixels)

6897 (2977; 10,643)

min. 0, max. 31,383

–

6122.5 (2667; 10,228)

min. 0, max. 25,375

–

10,851 (8057; 19,008)

min. 3388, max. 31,383

–

< 0.0001^#

Vitreomacular traction

24.8%

47

27.4%

45

8.0%

2

0.036^§

Epiretinal membrane

24.8%

47

23.9%

39

32.0%

8

0.315^§

Surgeon A/B/C

A: 28.0%/B: 38.6%/C: 33.3%

A: 53/B: 73/C:63

83.0%/84.9%/92.1%

A: 44/B: 62/C: 58

A: 17%/B: 15.1%/C: 7.9%

A: 9/B: 11/C: 5

0.301^$

Triamcinolon use

64.00%

121

87.6%

106

12.4%

15

0.66^§

VA postop (logMAR)

0.4 (0.3; 0.7)

min. 0, max. 1.9

–

0.4 (0.3; 0.6)

min. 0, max. 1.4

–

0.9 (0.8; 1.1)

min. 0.5, max. 1.9

–

< 0.0001^#